PHARMANAUS: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMANAUS
Largest movements
- Cash -€22,429
down €22,429 (-33.4%), from €67,074 to €44,645
mainly Current investments (-€16,485) and Net result for the year (-€10,886)
- Current investments +€16,485
up €16,485 (+1.5%), from €1.1m to €1.1m
No liability line moved by more than 1% of the balance sheet total.
- Gross operating margin -€5,870
down €5,870, from €3,142 to -€2,729
- Depreciation -€1,587
down €1,587 (-13.7%), from €11,560 to €9,973
- Taxes -€342
down €342 (-40.6%), from €842 to €500
- Financial charges +€262
up €262 (+1.7%), from €15,013 to €15,275
- Financial income +€165
up €165 (+0.9%), from €18,186 to €18,351
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,192,366 | €1,178,191 | -€14,175 | -1.2% |
| Fixed assets | 21/28 | €34,214 | €24,241 | -€9,973 | -29.1% |
| Tangible fixed assets | 22/27 | €34,214 | €24,241 | -€9,973 | -29.1% |
| Furniture and vehicles | 24 | €34,214 | €24,241 | -€9,973 | -29.1% |
| Current assets | 29/58 | €1,158,152 | €1,153,950 | -€4,202 | -0.4% |
| Amounts receivable within one year | 40/41 | €5,663 | €7,163 | +€1,500 | +26.5% |
| Trade receivables | 40 | €5,663 | €5,663 | = | 0.0% |
| Other amounts receivable | 41 | - | €1,500 | +€1,500 | |
| Current investments | 50/53 | €1,084,416 | €1,100,901 | +€16,485 | +1.5% |
| Cash at bank and in hand | 54/58 | €67,074 | €44,645 | -€22,429 | -33.4% |
| Deferred charges and accrued income | 490/1 | €999 | €1,242 | +€243 | +24.3% |
| Total equity and liabilities | 10/49 | €1,192,366 | €1,178,191 | -€14,175 | -1.2% |
| Equity | 10/15 | €644,120 | €633,235 | -€10,886 | -1.7% |
| Contributions | 10/11 | €388,600 | €388,600 | = | 0.0% |
| Reserves | 13 | €255,300 | €244,300 | -€11,000 | -4.3% |
| Distributable reserves | 133 | €255,300 | €244,300 | -€11,000 | -4.3% |
| Profit (loss) carried forward | 14 | €220 | €335 | +€114 | +52.0% |
| Amounts payable | 17/49 | €548,246 | €544,957 | -€3,289 | -0.6% |
| Amounts payable within one year | 42/48 | €535,146 | €531,738 | -€3,408 | -0.6% |
| Trade debts | 44 | €1,306 | €1,336 | +€30 | +2.3% |
| Suppliers | 440/4 | €1,306 | €1,336 | +€30 | +2.3% |
| Taxes, remuneration and social security | 45 | €4,377 | €2,369 | -€2,008 | -45.9% |
| Taxes | 450/3 | €4,377 | €2,369 | -€2,008 | -45.9% |
| Other amounts payable | 47/48 | €529,463 | €528,033 | -€1,430 | -0.3% |
| Accrued charges and deferred income | 492/3 | €13,100 | €13,219 | +€119 | +0.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €11,560 | €9,973 | -€1,587 | -13.7% |
| Other operating charges | 640/8 | €868 | €760 | -€107 | -12.4% |
| Gross operating margin | 9900 | €3,142 | -€2,729 | -€5,870 | |
| Operating profit (loss) | 9901 | -€9,286 | -€13,462 | -€4,176 | -45.0% |
| Financial income | 75/76B | €18,186 | €18,351 | +€165 | +0.9% |
| Recurring financial income | 75 | €18,186 | €18,351 | +€165 | +0.9% |
| Financial charges | 65/66B | €15,013 | €15,275 | +€262 | +1.7% |
| Recurring financial charges | 65 | €15,013 | €15,275 | +€262 | +1.7% |
| Profit (loss) for the period before taxes | 9903 | -€6,113 | -€10,385 | -€4,272 | -69.9% |
| Income taxes | 67/77 | €842 | €500 | -€342 | -40.6% |
| Profit (loss) for the period | 9904 | -€6,955 | -€10,886 | -€3,930 | -56.5% |
| Profit (loss) for the period to be appropriated | 9905 | -€6,955 | -€10,886 | -€3,930 | -56.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.